2013
DOI: 10.1590/1516-3180.2013.1313474
|View full text |Cite
|
Sign up to set email alerts
|

SAPS 3, APACHE IV or GRACE: which score to choose for acute coronary syndrome patients in intensive care units?

Abstract: CONTEXT AND OBJECTIVE: Acute coronary syndromes (ACS) are a common cause of intensive care unit (ICU) admission. Specific prognostic scores have been developed and validated for ACS patients and, among them, GRACE (Global Registry of Acute Coronary Events) has had the best performance. However, intensive care clinicians generally use prognostic scores developed from heterogeneous populations of critically ill patients, such as APACHE IV (Acute Physiologic and Chronic Health Evaluation IV) and SAPS 3 (Simplifie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 30 publications
0
13
1
Order By: Relevance
“…Although most studies aimed to validate SAPS III on a broad population in medical, surgical or mixed ICUs, nine studies (32.1%) applied SAPS III to patients with specific conditions such as cancer [ 15 , 20 ], elderly [ 17 ], acute kidney injury (AKI) [ 18 , 21 , 31 ], acute coronary syndromes [ 23 ], septic shock [ 30 ] and transplant patients [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…Although most studies aimed to validate SAPS III on a broad population in medical, surgical or mixed ICUs, nine studies (32.1%) applied SAPS III to patients with specific conditions such as cancer [ 15 , 20 ], elderly [ 17 ], acute kidney injury (AKI) [ 18 , 21 , 31 ], acute coronary syndromes [ 23 ], septic shock [ 30 ] and transplant patients [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…Few published studies are available to provide meaningful comparisons with the subgroup results from our study. Most describe smaller patient populations outside the U.S. (6,16,17,18). Previous use of APACHE IV to predict outcomes in patients with sepsis reported AUROCs ranging from 0.67 to 0.94 (6,16,19).…”
Section: Discussionmentioning
confidence: 99%
“…Our findings are important because although general severity scoring systems like APACHE IVa are not optimized for use in specific ICU patient subgroups, they are often used in this manner to make implications regarding quality of care (6,(16)(17)(18)(19)(21)(22)(23)(24)(25)(26). In addition to the subgroups discussed above, previous studies have employed general severity scoring system to predict outcomes in subgroups of patients with acute coronary syndrome (17), acute kidney failure (21), malignancy (22), organ transplantation (23), ECMO (24), cardiac surgery (25) and survivors of cardiac arrest (4,26). Many of these studies report AUROCs inferior to our 2VSS referent (6,19,20,(23)(24)(25)(26).…”
Section: Discussionmentioning
confidence: 99%
“…Of previous studies comparing the APACHE IV and SAPS 3 prognostic models, two regarding general ICU patients showed that the APACHE IV model had better discriminatory capability than SAPS 3 [9,29], but other studies for acute kidney injury and acute coronary artery syndrome patients showed that the two models have similar discriminatory performance [10,11]. Additionally, one study reported that the discrimination and calibration of APACHE II are similar to those of SAPS 3 [26].…”
Section: Discussionmentioning
confidence: 99%
“…The APACHE IV model showed good discrimination and calibration in the United States where the model was developed [5]. Outside the United States, recent studies have demonstrated that the discriminatory performance of APACHE IV was good [8,9,10,11,12]. However, its performance has not yet been validated in Korea.…”
Section: Introductionmentioning
confidence: 99%